Higher expression levels of TRPM4 and TRPV2 in UVM were significantly associated with pro-cancer signaling pathways, such as P13K-AKT-mTOR signaling pathway, hypoxia, p53 pathway, TGFβ signaling pathway, G2M checkpoint, angiogenesis, proliferation, inflammation and inflammatory response. Here, TRPV2 is linked to cancer.